Medicine for treating post-traumatic intracranial-hypotension syndrome

Abstract

The invention discloses a medicine for treating post-traumatic intracranial-hypotension syndrome, and the medicine is used for solving the treatment problem of post-traumatic intracranial-hypotension syndrome. The medicine is characterized by being formed by processing various traditional Chinese medicines and being prepared from the following raw materials in parts by weight: 10-20 parts of ardisiae japonica, 8-15 parts of herb of denseflower bulbophyllum, 8-15 parts of herba aistolochiae, 6-10 parts of sunglo, 6-10 parts of vandenboschia auriculata, 8-15 parts of semen cuscutae, 6-10 parts of Chinese starjasmine stems, 8-15 parts of angelica sinensis and 3-6 parts of azurite ores. According to the clinical experiment, the medicine has the characteristics of good curative effect and high safety in treating the post-traumatic intracranial-hypotension syndrome, and is worthy of being popularized and applied clinically.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating post-traumatic hypotension syndrome. Background technique [0002] In general, the intracranial pressure after craniocerebral injury often rises to varying degrees, and those who manifest as low intracranial pressure are rare. Occasionally, some patients had elevated intracranial pressure in the early post-injury period, and then developed intracranial hypotension. The incidence rate is about 5%, which is intracranial hypotension syndrome (IHS). This low intracranial pressure may be caused by cerebral vasospasm after injury, which affects the function of choroid plexus to secrete cerebrospinal fluid. Inhibition may also be secondary to cerebrospinal fluid leakage, shock, severe dehydration, hyponatremia, hyperventilation, and excessive cerebrospinal fluid released during surgery or lumbar puncture, etc. In addition, due to the strong leakage of ...

AI Technical Summary

Problems solved by technology

Simply stimulating cerebrospinal fluid secretion to increase intracranial pressure does not improve the initiating factors of choroidal vasomotor dysfunction and arachnoid granule overabsorption after trauma

This kind of treatment is often not easy to control the effect. If it is not enough, even if the secretion of cerebrospinal fluid increases, it will not be improved due to the disorder of choroidal vasomotor function and excessive absorption of arachnoid granules, so the intracranial pressure will not be improved, or it will fall again after a temporary rise; Excessive stimulation is also easy to overcompensate and cause secondary increase in intracranial pressure